BRIEF-Core Laboratories Provides Q1 Outlook
Feb 1 (Reuters) - Core Laboratories NV (CLB):
* FOURTH QUARTER REVENUE OF $128 MILLION
* FOURTH QUARTER GAAP EPS OF $0.14; EX-ITEMS, $0.20
* LOOKING FORWARD INTO 2023, SEES CRUDE-OIL MACRO
FUNDAMENTALS
CONTINUING TO SUPPORT MULTI-YEAR RECOVERY CYCLE FOR OIL,GAS
INDUSTRY
* PROJECTS FIRST QUARTER 2023 REVENUE TO RANGE FROM $125
MILLION
TO $129 MILLION
* EPS FOR THE FIRST QUARTER OF 2023 IS EXPECTED TO BE $0.14
TO
$0.19
* Q4 EARNINGS PER SHARE VIEW $0.20, REVENUE VIEW $130.3
MILLION --
REFINITIV IBES DATA
* Q1 EARNINGS PER SHARE VIEW $0.17, REVENUE VIEW $126.9
MILLION --
REFINITIV IBES DATA
Further company coverage:
Log In Required
Line of Credit Log In Required
